- Home
- UUUU vs IDYA Comparison
UUUU vs IDYA Comparison
Compare UUUU & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUUU
- IDYA
- Stock Information
- Founded
- UUUU 1987
- IDYA 2015
- Country
- UUUU United States
- IDYA United States
- Employees
- UUUU 1370
- IDYA N/A
- Industry
- UUUU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- UUUU Industrials
- IDYA Health Care
- Exchange
- UUUU Nasdaq
- IDYA Nasdaq
- Market Cap
- UUUU 2.1B
- IDYA 2.2B
- IPO Year
- UUUU N/A
- IDYA 2019
- Fundamental
- Price
- UUUU $8.87
- IDYA $24.27
- Analyst Decision
- UUUU Strong Buy
- IDYA Strong Buy
- Analyst Count
- UUUU 3
- IDYA 13
- Target Price
- UUUU $8.42
- IDYA $51.36
- AVG Volume (30 Days)
- UUUU 15.3M
- IDYA 1.0M
- Earning Date
- UUUU 08-06-2025
- IDYA 08-08-2025
- Dividend Yield
- UUUU N/A
- IDYA N/A
- EPS Growth
- UUUU N/A
- IDYA N/A
- EPS
- UUUU N/A
- IDYA N/A
- Revenue
- UUUU $69,586,000.00
- IDYA $7,000,000.00
- Revenue This Year
- UUUU N/A
- IDYA $115.83
- Revenue Next Year
- UUUU $178.01
- IDYA $252.50
- P/E Ratio
- UUUU N/A
- IDYA N/A
- Revenue Growth
- UUUU 59.09
- IDYA N/A
- 52 Week Low
- UUUU $3.20
- IDYA $13.45
- 52 Week High
- UUUU $10.41
- IDYA $44.04
- Technical
- Relative Strength Index (RSI)
- UUUU 61.51
- IDYA 59.26
- Support Level
- UUUU $8.62
- IDYA $24.46
- Resistance Level
- UUUU $10.41
- IDYA $26.16
- Average True Range (ATR)
- UUUU 0.70
- IDYA 1.15
- MACD
- UUUU -0.07
- IDYA 0.14
- Stochastic Oscillator
- UUUU 56.37
- IDYA 60.87
About UUUU Energy Fuels Inc (Canada)
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.